AgomAb Therapeutics NV ADR (AGMB) Ownership Overview
3.24% Mutual Funds
44.55% Other Institutional Investors
0.14% ETFs
52.07% Public Companies and
Individual Investors
The ownership structure of AgomAb Therapeutics NV ADR (AGMB) stock is a mix of institutional, retail, and individual investors. Approximately 47.93% of the company’s stock is owned by Institutional Investors, and 52.07% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,596,892 | Institution | 3.24% | 25,198,956 | |
| 600,000 | Institution | 1.22% | 9,468,000 | |
| 67,842 | Institution | 0.14% | 1,070,547 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,596,892 | Institution | 3.24% | 25,198,956 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 67,842 | Institution | 0.14% | 1,070,547 |
FAQ
Who Owns AgomAb Therapeutics NV ADR (AGMB)?
Currently, no data Available
What percentage of AgomAb Therapeutics NV ADR (AGMB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 44.55% of AgomAb Therapeutics NV ADR (AGMB) stock is held by institutional investors.
What percentage of AgomAb Therapeutics NV ADR (AGMB) stock is held by retail investors?
According to the latest TipRanks data, approximately 52.07% of AgomAb Therapeutics NV ADR (AGMB) stock is held by retail investors.
Who owns the most shares of AgomAb Therapeutics NV ADR (AGMB)?
Federated Hermes Equity Funds owns the most shares of AgomAb Therapeutics NV ADR (AGMB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.